mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.05 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.3 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |